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Pseudomonas aeruginosa strain 1001 produces an esterase (EstA) that can
hydrolyse the racemic methyl ester of b-acetylthioisobutyrate to produce
the (D)-enantiomer, which serves as a precursor of captopril, a drug used
for treatment of hypertension. We show here that PA2949 from P. aerugi-
nosa PA01, a homologue of EstA, can efficiently be expressed in an enzy-
matically active form in E. coli. The enzyme is membrane-associated as
demonstrated by cell fractionation studies. PA2949 was purified to homo-
geneity after solubilisation with the nonionic detergent, Triton X-100, and
was shown to possess a conserved esterase catalytic triad consisting of
Ser137–His258–Asp286. Our results should allow the development of an
expression and purification strategy to produce this biotechnologically rele-
vant esterase in a pure form with a high yield.
Carboxyl esterases (EC 3.1.1.1) and lipases (EC
3.1.1.3), usually referred to as lipolytic enzymes,
hydrolyse ester bonds of a wide range of lipidic sub-
strates [1]. They exert various cellular functions in ani-
mals, plants and microorganisms [2–4]. The present
classification scheme consists of 15 bacterial lipase
families, which contain several hundreds of protein
sequences and three dimensional structures [5,6].
Despite relatively low amino acid sequence similarity
(typically below 20%) lipolytic enzymes have a com-
mon a/b-hydrolase fold, characterised by a central
hydrophobic sheet composed of mostly eight b-strands,
which are connected by a-helices [7]. These enzymes
are characterised by a typical GXSXG-consensus motif
containing the catalytic serine, which forms the cat-
alytic triad with histidine and aspartate residues [8].
Glycine residues of the GXSXG-motif account for the
localisation of the catalytic serine on top of a sharp
turn preceded by an a-helix followed by a b-strand.
This structural motif, named nucleophilic elbow, is
essential for substrate hydrolysis and represents one of
the best conserved structural motifs among a/b-hydro-
lases. The catalytic triad and the residues forming the
oxyanion hole, which stabilises the tetrahedral interme-
diates formed during the hydrolysis, are structurally
strongly conserved in all a/b-hydrolases [9].
Abbreviations
DAT, (D)-b-acetylthioisobutyric acid; EDTA, ethylenediaminetetraacetic acid; IMAC, immobilised metal affinity chromatography; MUB,
4-methylumbelliferyl butyrate; PMSF, phenylmethylsulfonyl fluoride; pNPC6, p-nitrophenyl hexanoate; pNPP, p-nitrophenyl palmitate; SDS/
PAGE, sodium dodecyl sulphate polyacrylamide gel electrophoresis; THL, tetrahydrolipstatine.
484 FEBS Open Bio 6 (2016) 484–493 ª 2016 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
Although many structural features of a/b-hydrolases
are similar, these enzymes show a wide range of func-
tionalities [10]. In recent years, the number of
biochemical and structural data about lipolytic
enzymes are rapidly increased, however, the under-
standing of structure-function relationship is still lim-
ited [11]. Nowadays, lipolytic enzymes are broadly
used as industrial biocatalysts, since many of them are
fairly stable in harsh conditions that are often needed
for industrial bioprocess [12,13], for example, high
temperatures, presence of organic solvents or high
ionic strength buffers. Moreover, their enantio-, stereo-
and regioselectivity allow controlled organic synthesis
reactions using complex unnatural substrates, as, for
example, precursors for the biopharmaceuticals pacli-
taxel [14], naproxen [15] and captopril [16]. The latter
is the first drug used for the treatment of hypertension,
congestive heart failure and diabetic nephropathy,
which acts by inhibiting angiotensin-converting enzyme
[16]. Presently, captopril is still prescribed and dis-
tributed under the trade name Capoten. Its chemical
synthesis requires the optically pure key intermediate,
(D)-b-acetylthioisobutyric acid (DAT) as the inhibiting
potency of the (D)-enantiomer is 100-fold higher than
of the (L)-enantiomer [16,17]. To overcome the labori-
ous and expensive chemical synthesis of optically active
DAT, Sakimae et al. [18] screened for microorganisms
producing esterases, which can stereoselectively hydrol-
yse the racemic methyl ester of b-acetylthioisobutyrate
[18]. The functional screening revealed several strains
capable of DAT synthesis with Pseudomonas strains
producing DAT of highest optical purity [18].
The esterase EstA from P. aeruginosa 1001 was
cloned, overexpressed and shown to produce DAT
[19,20]. However, expression of EstA in E. coli resulted
in low enzymatic activity presumably caused by forma-
tion of protein aggregates, which could not be com-
pletely abolished by fusion with maltose-binding
protein [19,20]. Here, we report cloning, expression
and purification of the protein encoded by open read-
ing frame pa2949 from P. aeruginosa PA01, which is
homologous to EstA from P. aeruginosa 1001. We
have developed a system for efficient expression of
highly active PA2949 in common laboratory strain
E. coli BL21(DE3). Biochemical analysis showed
esterase but no lipase activity of PA2949, and enzyme
activity could be inhibited by serine-hydrolase
inhibitors. Furthermore, we showed that PA2949 is
localised in the membrane of E. coli prompting us to
develop a detergent-based purification method, which
yielded mg amounts of enzymatically active protein.
Our data demonstrates that PA2949 can be function-
ally expressed, easily purified and adequately stabilised
thus making it available for a range of different
biotechnological applications.
Materials and methods
Bioinformatic analysis
Amino acid sequences were analysed and aligned using the
BLAST search and alignment tool of the Universal Protein
Knowledge Base (www.uniprot.org) [21]. Signal peptide
cleavage sites were predicted by two different methods,
namely the Hidden Markov Model (Signal P-HMM) [22]
and neural network (Signal P-NN) [22]. Signal peptides
were distinguished from nonsignal peptides by a threshold
D-score of SignalP-NN higher than 0.5 and by a threshold
C-score of SignalP-HMM higher than 0.95. The transmem-
brane helix was predicted using the Toppred [23] online
tool with a score higher than 0.8.
Cloning, site-directed mutagenesis, expression
and purification of PA2949
Restriction endonucleases, Pfu DNA polymerase and bacte-
riophage T4 DNA ligase (Thermo Scientific, Darmstadt,
Germany) reactions were carried out as recommended by
the manufacturers. DNA fragments were analysed on 1%
(w/v) agarose gels. Plasmid DNA was purified using the
InnuPREP DOUBLE pure kit (Analytik Jena, Jena, Ger-
many) or, for genomic DNA from P. aeruginosa PA01
using the DNeasy tissue kit (Qiagen, Hilden, Germany).
Used strains and plasmids are listed in Table 1 [24–27].
The pa2949 gene was amplified by standard PCR using
Pfu DNA polymerase, the genomic DNA of P. aeruginosa
PA01 as a template and oligonucleotide pair 50-AAACA
TATGAAACGATTCCTC-30/50-TCAGAGCTCCACCACC
ACCACCACCACGCGACCGGCCAC-30 encoding NdeI
and SacI restriction sites (underlined) and a C-terminal
His6-tag (bold). Primers were synthesised by MWG Bio-
tech. The pa2949 gene was cloned into NdeI and SacI
restriction sites of pET22b yielding expression plasmid
pET-pa2949 (Table 1) allowing for bacteriophage T7-RNA
polymerase-dependent expression from the T7 promoter.
The mutation of Ser137Ala in PA2949 was performed by
the Quik-change PCR method using Pfu DNA polymerase
(Invitrogen, Darmstadt, Germany), pET-pa2949 plasmid
and the complementary mutagenic oligonucleotide pair
50-TGGCCGGCAACGTCCCCATGGGCGGG-30/50-CCCG
CCCATGGGGCAGTTGCCGGCCA-30 (mutated codons
are underlined and nucleotides of the wild-type gene are
indicated in the subscript). Correctness of plasmids pET-
pa2949 and pET-pa2949_S137A was confirmed by DNA
sequencing (MWG Biotech, Ebersberg, Germany).
For the expression of PA2949 and PA2949 S137A,
E. coli BL21(DE3) cells transformed respectively with pET-
pa2949 and pET-pa2949_S137A were grown overnight at
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37 °C in a Luria–Bertani (LB) medium supplemented with
ampicillin (100 lgmL1). These cultures were used to
inoculate an expression culture in LB medium supple-
mented with ampicillin (100 lgmL1) to an initial
OD580 nm = 0.05. The cultures were grown at 37 °C until
they reached logarithmic phase (OD580 nm = 0.5–0.8) and
gene expression was induced by addition of isopropyl-b-D-
thiogalactosid (IPTG) to a final concentration of 0.4 mM.
After 2 h, cells were harvested by centrifugation at 4000 g
and 4 °C for 20 min and stored at 20 °C.
SDS/PAGE, zymography and immunodetection
Proteins were analysed by sodium dodecyl sulphate poly-
acrylamide gel electrophoresis (SDS/PAGE) under denatura-
tion conditions on 12% (w/v) gels as described by Laemmli
[28]. Esterase activity in SDS/PAGE gels was detected by
zymography using the fluorescent substrate 4-methylumbelli-
feryl butyrate (MUB) [29]. The proteins transferred from
SDS/PAGE gel to the polyvinylidene difluoride membranes
by western blotting [30] were detected using anti-His(C-
term)-HRP antibodies (Invitrogen) according the manufac-
turers’ instructions. The protein concentration was deter-
mined by the method of Bradford with bovine serum
albumin as a standard [31].
Cellular localisation, purification and biochemical
characterisation
Cellular localisation
Gene pa2949 was subcloned from pET-pa2949 into pBBR1m-
cs-3 behind the lac promoter using XbaI and SacI restriction
sites yielding plasmid pBBR-pa2949. E. coli DH5a cells har-
bouring pBBR-pa2949 were cultivated overnight in LB med-
ium supplemented with tetracycline (10 lgmL1) at 37 °C.
The cells were harvested by centrifugation (1 min, 19 000 g,
and 4 °C), resuspended in 100 mM Tris-HCl buffer (pH 8),
disrupted by sonication and total cell membranes were iso-
lated by ultracentrifugation (30 min, 180 000 g, 4 °C) [29,32].
Purification
The total membrane fraction containing PA2949 with a
C-terminal His6-tag was solubilised with 1% (w/v) Triton
X-100 by gentle agitation overnight at 4 °C. Solubilised
membranes were subjected to ultracentrifugation (30 min,
180 000 g, 4 °C) and PA2949 was purified from the super-
natant by immobilised metal affinity chromatography
(IMAC) using Ni-NTA agarose (Qiagen) [33]. All buffers
used were supplemented with (1% w/v) Triton X-100 to keep
PA2949 in soluble form. Purified PA2949 samples eluted
from the Ni-NTA column were transferred into Tris-HCl
buffer (100 mM, pH 8) containing 1% (v/v) Triton X-100 by
gel filtration using PD-10 column (GE Healthcare, Solingen,
Germany) according to the manufacturers’ protocol. The
purified protein was then stored at room temperature.
Enzyme activity assays
Enzymatic activities were determined in 96-well microplates
by adding 5 lL of enzyme sample to 200 lL of substrate
with p-nitrophenyl hexanoate (pNPC6) for esterase and p-
nitrophenyl palmitate (pNPP) for lipase activity [1].
Temperature optimum
Esterase activities were measured over a range of tempera-
tures from 10 °C to 70 °C as described previously [34].
Assays were performed in a 96-well microplate by adding
2 lL of enzyme sample to 200 lL of pNPC6 substrate.
pH and organic solvents stability
Esterase activities of PA2949 incubated for 1 h with buffers
of a pH range from 3 to 10.5 [34] or for 3 h with various
organic solvents (dimethyl sulfoxide, N, N-dimethyl for-
mamide, methanol, acetonitrile, ethanol, acetone, propan-2-
ol, diethyl ether, hexane, toluene) [34] were measured in a
96-well microplate by adding 2 lL of enzyme sample to
200 lL of pNPC6 substrate.
Table 1. Strains and plasmids used in this study.
Strains Genotype Source
E. coli DH5a supE44 D(lacZYA-argF)U196 (Φ80DlacZM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 [24]
E. coli BL21(DE3) F ompT hsdSB(rB
mB
) gal dcm (kIts857 indI sam7 nin5 lacUV5-T7gene1) [25]
P. aeruginosa PA01 Wild-type, originating from Dieter Haas laboratory (Lausanne, CH) [26]
Plasmids Description Source
pET22b+ ColE1 PT7Ф10 pelB Ap
r C-His6-‘Tag’ lacI
q Novagen
pBBR1mcs3 Cmr mob lacZa Plac PT7 Tcr [27]
pET22b-pa2949 pa2949H6 gene inserted in NdeI/SacI of pET22b(+) This study
pET22b-pa2949_S137A pa2949 gene with substitutions of Ser137 with Ala inserted in NdeI/SacI sites of pET22b(+) This study
pBBR1mcs3-pa2949 XbaI/SacI fragment of pET22b-pa2949 inserted in pBBR1mcs-3 This study
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Inhibition
The inhibition of PA2949 was tested according Asler et al.
[35] using THL, PMSF, paraoxon (all dissolved in propan-
2-ol) and the EDTA (dissolved in H2O). Inhibition of
PA2949 was performed by incubating enzyme aliquots with
the inhibitors for 3 h at the room temperature and subse-
quent determination of enzyme activity using pNPC6 as the
substrate.
Results and Discussion
Open reading frame PA2949 of P. aeruginosa
PA01 encodes a putative lipase
By searching the Pseudomonas genome database
(www.pseudomonas.com) [36] we have identified about
hundred genes of P. aeruginosa PA01 encoding puta-
tive lipolytic enzymes, among them ORF pa2949. This
gene of 948 bp length encodes a protein of Mr
34.8 kDa with a predicted Abhydrolase_6 Pfam
domain (PF12697) spanning residues 65–299 (Fig. 1A).
A BLAST search revealed homology of PA2949 with
known esterases and lipases, namely EstA from
P. aeruginosa 1001 [19,20], and two lipases from psy-
crophilic bacteria, Moraxella sp. lipase [37] and Psy-
chrobacter immobilis lipase [38] (Fig. 1B). The genes
encoding pa2949 from P. aeruginosa PA01 and estA
from P. aeruginosa 1001 share 99% identity (data not
shown), and the protein sequences are identical
(Fig. 1). The amino acid sequences of Moraxella sp.
and P. immobilis lipases are ~ 50% similar to the one
of PA2949. The sequence alignment revealed the
strictly conserved amino acid Ser137 embedded in the
conserved GXSXG-lipase motif, as well as Asp258 and
His286 predicted to form the catalytic triad of
PA2949.
Expression of PA2949 in E. coli BL21(DE3)
In order to obtain enzymatically active and soluble
PA2949, we constructed a heterologous expression sys-
tem using E. coli BL21(DE3) carrying plasmid pET-
pa2949. Bacteria were grown at 37 °C and expression
of pa2949 was induced by addition of 0.4 mM IPTG.
SDS/PAGE and western blot analyses revealed expres-
sion of a protein with an estimated molecular weight
of 35 kDa. In parallel, we measured significantly
increased esterase activity in the cell lysate of the
expression strain compared with the strain carrying the
empty vector (Fig. 2). Additionally, esterase activity of
the 35 kDa protein was detected by zymographic anal-
ysis. Interestingly, PA2949 did not show activity with
palmitic acid p-nitrophenyl ester considered as a typi-
cal lipase substrate. In conclusion, we could demon-
strate that PA2949 of P. aeruginosa can be
functionally expressed in E. coli BL21(DE3) and
displays esterase but not lipase activity.
PA2949 is localised in the membrane of E. coli
The subcellular localisation of a protein must be con-
sidered to develop an efficient purification protocol
[39]. As cellular localisation was unknown for PA2949
and its homologues, we first performed a bioinformatic
Fig. 1. Sequence analysis of PA2949. (A)
Molecular organisation of PA2949 from
P. aeruginosa PA01 showing putative
transmembrane domain (TM, amino acids
4-24) and catalytic a/b-hydrolase domain
(amino acids 65–299). The cleavage site
for the predicted signal peptide (LLA) and
the putative active site residues (Ser, Asp,
His) are marked by the grey pin and the
red diamonds respectively. (B) Sequence
alignment of PA2949 with EstA from
P. aeruginosa 1001 [19,20], Moraxella sp.
lipase MsLip [37] and
Psychrobacter immobilis lipase PiLip [50].
Residues identical and similar in at least
three sequences were shaded in black and
yellow respectively.
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analysis revealing either a putative N-terminal type I
signal peptide spanning amino acids 1–28 or a putative
transmembrane helix spanning amino acids 4–24 sug-
gesting a periplasmic, extracellular or membrane locali-
sation. Many membrane proteins containing
transmembrane helices display anomalous migration in
SDS/PAGE [40] that is often heat inducible [41], and
caused by differences in binding of SDS to heat-trea-
ted and untreated forms of the protein. Hence, we
have tested the effect of temperature on the elec-
trophoretic mobility of PA2949 and have shown that
PA2949 migrated faster after incubation at 99 °C prior
to electrophoresis compared to the sample incubated
at room temperature indicating that it is a membrane
protein (data not shown).
Therefore, we have experimentally separated mem-
branes and soluble fraction of E. coli cells expressing
PA2949. For this experiment, we expressed PA2949 in
E. coli DH5a under the control of the weak lac pro-
moter rather than the strong T7 promoter to avoid
overloading of membranes and prevent mislocalisation
[42]. The gene pa2949 was subcloned from plasmid
pET-pa2949 into the broad host range vector
pBBR1mcs-3 [43] and expression was performed in
E. coli DH5a without induction. Cells were disrupted
by sonication, membranes were isolated by ultracen-
trifugation, analysed by SDS/PAGE and western blot-
ting and PA2949 was detected solely in the membrane
fraction (Fig. 3). Thus, recombinant PA2949 expressed
in E. coli is localised in the cell membrane, however,
the localisation of PA2949 in the homologous host
P. aeruginosa is still unknown. As E. coli and
P. aeruginosa belong to the same class of Gamma-pro-
teobacteria and share evolutionarily conserved signal
recognition particles and Sec-translocation systems for
targeting membrane proteins [44] we predict membrane
localisation of PA2949 in P. aeruginosa as well.
Purification and biochemical characterisation of
PA2949
Purification of membrane proteins requires the usage
of detergents for solubilisation as well as to prevent
subsequent protein aggregation by stabilising
hydrophobic domains, which are naturally embedded
in the membrane [45]. Here, we have selected the non-
ionic detergent Triton X-100 commonly used for
purification of membrane proteins from E. coli [46] to
extract PA2949 from the membranes. Initially, the
total membrane fraction of E. coli BL21(DE3) express-
ing PA2949 was incubated for 1 h at room tempera-
ture with Triton X-100 at concentrations exceeding the
critical micellar concentration. Although, Triton X-100
in a concentration range from 0.5 to 2% (w/v) did not
reduce the esterase activity of PA2949, the protein was
not quantitatively solubilised from the membranes
(results not shown). Almost quantitative extraction of
PA2949 was achieved after overnight incubation of
membranes with detergent without losing esterase
activity. Solubilisation of membranes with Triton
X-100 and subsequent purification using immobilised
metal affinity chromatography yielded ~ 1 mg/Lculture/
Fig. 2. Expression and esterase activity of PA2949. (A) Coomassie Blue-stained SDS gel (12%) after separation of extracts from E. coli
BL21(DE3) cells carrying empty vector (EV, pET22b) or PA2949 expression vector (pET-pa2949). The gel was loaded with equal amount of
cell extracts collected before induction (0 h) and 1 or 2 h after induction with IPTG. Molecular weights of standard proteins (St) are indicated
on the left; the black arrow indicates overexpressed PA2949. (B) Western blot of samples shown in A using anti-His-tag antibodies. (C)
Esterase activity of cell extracts from samples shown in Fig. 2A. The results  standard deviations are means of three independent
experiments, each set in triplicate.
488 FEBS Open Bio 6 (2016) 484–493 ª 2016 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
Expression of P. aeruginosa PA2949 in E. coli F. Kovacic et al.
OD580 nm of pure PA2949 (Fig. 4). Purified PA2949
preparation had 198.8  5.1 Umg1-specific esterase
activity measured with p-nitrophenyl hexanoate at
30 °C that corresponds to approximately 60–70% of
total esterase activity of membrane fraction of E. coli
BL21(DE3)-expressing PA2949. Incubation of PA2949
with various buffers (pH 3.0–10.5) revealed that activ-
ity was best retained in Tris-HCl buffer pH 8.0 at
room temperature (Table 2), whereas storage at 4 °C
or freezing (also in the presence of 30% glycerol) lead
to the precipitation and inactivation of PA2949.
The similarity of the PA2949 amino acid sequence
with psychrophilic esterases (Fig. 1) prompted us to
test if PA2949 retained its activity also at low tempera-
tures. Determination of esterase activities at tempera-
tures ranging from 10 °C to 70 °C revealed 30 °C as
the optimal temperature (Fig. 5). Interestingly, even at
a temperature of 10 °C PA2949 retained 47% of its
activity measured at 30 °C. This data indicate that
PA2949 behaves similar to psychrophilic rather than
mesophilic enzymes that are usually inactive at low
temperatures [47].
Fig. 3. Subcellular localisation of recombinant PA2949 in E. coli
DH5a. The membranes (M) and soluble fraction (SF) of E. coli DH5a
carrying pBBR-pa2949 or pBBR1mcs-3 (empty vector, EV) were
separated by ultracentrifugation and equal amount of proteins from
each cell fraction were analysed by western blotting using anti-His-
tag antibodies (upper panel) and by SDS/PAGE (lower panel).
Molecular weights of protein standard (St) are indicated on the left.
Fig. 4. Purification of recombinant PA2949 from E. coli BL21(DE3).
(A) Coomassie Blue-stained SDS-gel (12%) showing fractions
obtained by purification of PA2949 and its catalytic inactive variant
PA2949_S137A using a Ni-NTA column. L, load fraction containing
membranes of E. coli BL21(DE3) expressing PA2949 solubilised with
Triton X-100, FT, flow through; W, fraction after washing with buffer
containing 60 mM imidazole and E, fraction eluted from the column
with buffer containing 250 mM imidazole. Molecular weights of
protein standard (St) are indicated on the left. The fraction containing
PA2949_S137A is shown on a separate SDS gel (indicated by a
dashed line). (B) Zymogram indicating esterase activity of purified
PA2949 (elution fraction shown in A) monitored under UV light using
the fluorescent substrate 4-methylumbelliferyl butyrate.
Table 2. pH stability of PA2949.
pH Activity  SD (%)
3.0 40.1  2.0
4.5 60.2  4.3
6.0 80.4  3.7
7.5 88.7  7.8
8.0 100.0  6.7
8.5 87.4  8.7
9.0 81.1  6.7
9.5 62.5  12.6
10.5 42.3  9.1
Esterase activities  standard deviations are means of three
independent experiments, each set in triplicate.
Fig. 5. Optimum temperature of PA2949. Esterase activities of
purified PA2949 measured at respective temperatures are shown
as relative activities compared with the highest activity measured
at 30 °C with 100% activity corresponding to the specific activity
of the wild-type (198.8  5.1 Umg1). The results  standard
deviations are means of three independent experiments, each set
in triplicate.
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Stability in the presence of organic solvents is an
essential property of enzymes used as biocatalysts for
organic synthesis [13]. Membrane proteins usually con-
tain membrane-embedded domains and soluble
domains protruding into the surrounding water milieu,
which are differently resistant to hydrophobic (high
log P) and hydrophilic (low log P) solvents [48].
Therefore, we have tested the stability of PA2949 after
incubation with various solvents (Table 3). Notably,
PA2949 was fairly stable in most of the tested solvents,
some of them, for example, diethyl ether and methanol
even enhanced its activity, but some hydrophilic sol-
vents (acetonitrile, ethanol and propan-2-ol) severely
reduced esterase activity.
Binding of substrate-mimicking inhibitors to the
enzyme active site can provide valuable data for
understanding the catalytic mechanism [49] as well as
regio- and enantio preference [50] of lipases. We thus
determined the inhibition kinetics of PA2949 using
typical lipase inhibitors containing long hydrophobic
acyl chains, namely tetrahydrolipstatine (THL) [51],
the short acyl chain arylesterase inhibitors paraoxon
[52], phenylmethylsulfonyl fluoride (PMSF) [53] and
an inhibitor of metal-dependent enzymes, ethylenedi-
aminetetraacetic acid (EDTA) [54]. Resistance
towards EDTA indicated that PA2949 is not a metal-
loenzyme (Fig. 6). All three inhibitors targeting the
catalytic serine residue (THL, PMSF and paraoxon)
inhibited PA2949 activity, although to a different
degree (Fig. 6). Incubation of PA2949 with THL for
3 h resulted in 28% of residual activity, whereas
THL, PMSF and paraoxon completely abolished
PA2949 activity indicating irreversible inhibition.
Phosphonate or sulphonate inhibitors covalently
linked to the catalytic serine, mimic the first tetrahe-
dral intermediate (before dissociation of alcohol moi-
ety) and the second tetrahedral intermediate (after
dissociation of alcohol moiety) formed during ester
hydrolysis respectively [10]. These results provided
further evidence that PA2949 contains in its active
site a nucleophlic serine. Using site-directed mutagene-
sis, we constructed variant PA2949 S137A, which was
purified (Fig. 4), but did not show any esterase activ-
ity. These results are in agreement with the bioinfor-
matic prediction of Ser137 as the catalytic residue.
Additionally, our data suggest a rather narrow active
site of PA2949 because the bulky inhibitor molecule
THL apparently could not efficiently bind to the
Table 3. Stability of PA2949 in the presence of various organic
solvents.
Organic solvent
Concentration
(%, v/v) Log P
Residual
activity  SD (%)a
DMSO 30 1.300 82.2  4.7
N,N-Dimethyl
formamide
30 1.000 26.0  2.7
Methanol 30 0.760 111.0  11.1
Acetonitrile 30 0.330 0.0  0.0
Ethanol 30 0.240 5.4  0.2
Acetone 30 0.230 79.1  5.6
Propan-2-ol 30 0.074 8.1  0.4
Diethyl ether 30 0.850 125.6  8.8
Hexane 5 3.500 106.9  5.8
Toluene 5 2.500 65.1  2.7
aResidual esterase activities are expressed as a percentage of
PA2949 activity in buffer without organic solvent.  standard devia-
tions are means of three independent experiments, each set in
triplicate.
Fig. 6. Inhibition of PA2949. Residual esterase activities were determined after preincubation for 3 h of 1.7 lM of PA2949 with 10 mM
EDTA, 2 mM THL, 1 mM paraoxon and 1 mM PMSF at room temperature. Inhibited PA2949 samples (15 lg) were incubated with 100 lL of
substrate at 30 °C and residual esterase activity was measured. PA2949 samples treated with propan-2-ol and water represent noninhibited
controls. On the right, the chemical structures of inhibitors THL, paraoxon and PMSF are shown with the bonds to be hydrolysed indicated
in red. The results  standard deviations are means of three independent experiments, each set in triplicate. The standard deviations were
below 8%.
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active site. The preparation of stable PA2949-PMSF
and PA2949-paraoxon complexes we have described
here will be used for further crystallographic and
kinetic studies.
Biotechnological potential of PA2949
PA2949 from P. aeruginosa PA01 is homologous to
the esterase EstA from P. aeruginosa 1001, which
was previously shown to hydrolyse racemic b-acet-
ylthioisobutyrate methyl ester to form enantiopure
DAT [19,20], an important intermediate in the synthe-
sis of pharmaceuticals [16]. However, heterologous
expression of enzymatically active EstA turned out to
be difficult because of poor solubility and low produc-
tion yield [20]. EstA was predicted to be a soluble pro-
tein with an N-terminal signal sequence instead of a
transmembrane helix [19,20]. This misleading assump-
tion resulted in the construction of an expression sys-
tem where maltose-binding protein (which was shown
to enhance the solubility of proteins) was fused to the
N-terminus of EstA resulting in blocking of EstA
secretion and expression of only poorly active enzyme
[20]. Using the pa2949 gene encoding the full-length
protein with C-terminal His6-tag we have successfully
expressed mg/Lculture quantities of active PA2949
located in the membrane of the common laboratory
strain E. coli. Subsequent extraction with the nonionic
detergent Triton X-100 allowed for the efficient purifi-
cation of up to 70% of PA2949 from membranes and
enabled storage at room temperature without loss of
activity. The biochemical characterisation of PA2949
revealed 30 °C as the optimal temperature for catalysis
(Fig. 5), high stability at pH 7.5–8.5 (Table 2), and
notable resistance to various organic solvents
(Table 3). Interestingly, a study of DAT production
with whole cells of P. putida MR-2068, which
expressed a PA2949 homologue revealed pH 7.5 and
45 °C as the best conditions [55]. At higher tempera-
tures and in alkaline pH spontaneous hydrolysis of the
racemic b-acetylthioisobutyrate methyl ester was
observed, thereby reducing the optical purity of DAT
[55]. In summary, PA2949 possesses biochemical prop-
erties, which match the requirements for the enzymatic
synthesis of DAT as well as its subsequent extraction
with organic solvent.
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